Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China’s Pharma Market to Reach $310 Billion in Revenues by 2020

publication date: Oct 22, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China’s pharmaceutical market will continue to grow at a 17% annual rate from now until 2020, according to analysts. That’s a strong number, even though it is a slowdown from the 21% annual increases over the past five years. In 2012, China booked $98.4 billion in pharmaceutical revenues. By 2020, the market will more than triple, reaching $310 billion. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors